Colorectal Cancer Flashcards

1
Q

most common site of bowel affected by colorectal Ca?

A

rectum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

single biggest RF for colorectal Ca?

A

age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RFs for colorectal Ca?

A

increasing AGE
FH-lifetime risk 1 in 10 if 1 first degree relative diagnosed under the age of 45
inherited conditions-FAP and HNPCC, FAP-mutated APC gene, predisposition to multiple benign polyp development in the large bowel, mutation arises sporadically in 25% of cases.
HNPCC (Lynch syndrome)-increased risk of bowel Ca, uterine Ca, ovarian Ca, stomach Ca, pancreatic Ca, bile duct and bladder Cas. ?FH of Ca at a young age.
other polyposis syndromes
BRCA 1 gene faults in women under 50yrs
IBD-UC more so
previous bowel Ca
previous Ca-prostate, lung, endometrial, lymphoma
other medical conditions-DM, acromegaly, gallstones
infections-H pylori, HPV
radiation exposure
diet-rich in red meat and fat, low in fibre-prolonged gut transit time-increase time bowel epithelium exposed to carcinogens in stool (?and irritation to bowel mucosa impacted stools increase cell turnover), folate and calcium
obesity, smoking, high alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is FAP?

A

familial adenomatous polyposis
autosomal dominant inherited condition responsible for 1% of all colorectal cancer
APC gene mutation (a TSG) on chromosome 5
prophylactic colectomy offered in teenage years as all patients will develop CR cancer by age of 40
also susceptible to polyps elsewhere e.g. cystic gland polyps in the duodeum, proximal stomach, and extraintestinal lesions e.g. osteomas, epidermoid cysts and desmoid tumours.
most common cause of death in colectomized patients=dudoenal Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

genetics underlying HNPCC?

A

autosomal dominant inheritence
microsatellite instability-naturally occuring highly repeated short DNA sequences are shorter or longer than normal
mutated DNA mismatch-repair genes e.g. hMSH2 and hMLH1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

role of MRI scanning in rectal cancer?

A

used to stage rectal cancer by looking for local invasion and nodal disease, and determine if need for radiotherapy pre-op.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is Gardners syndrome?

A

now considered variant of FAP
autosomal dominant inheritence
due to APC mutation on chromosome 5 causing multiple colonic polyps AND extra colonic diseases-skull osteoma, thyroid Ca, epidermoid cysts (often called sebaceous cysts-central punctum from sebum)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how does a colorectal Ca evolve from a polyp?

A

develops over a 10 year period from polyp to invasive cancer
polyp=areas of cells proliferating more quickly than the rest of the bowel mucosa, increased number of cell turnover cycles increases likelihood of something going wrong-mutations developing, and over time mutations accumulate in sequence, and multiple mutations responsible for cancer development
e.g. p53, deletion of colorectal gene (DCC), K-Ras and APC.
risk of adenoma malignant transformation increases with their size, how long been present, and more likely with sessile or flat polyps.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the role of aspirin in reducing risk of CR cancer?

A

been shown to have a protective effect due to inhibitory effect on COX-2 which is found in high concentrations in colorectal tissue and promotes polyp growth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

why is surgical removal of primary disease even in the case of metastatic disease still considered?

A

to reduce risk of bowel perforation and obstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how is neoadjuvant radiotherapy used in bowel Ca treatment?

A

used before surgery in rectal cancer to limit pelvic recurrence for low rectal tumours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why is radiotherapy ONLY used in rectal cancers and NOT colon cancers?

A

radiotherapy for colon would irradiate the small bowel aswell, causing enteritis and fistulae.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

current guidelines on bowel cancer screening?

A
FOB testing used for all men and women aged between 60 and 74, every 2 years.
if 3+ blood then colonoscopy
if 2+ discuss colonoscopy
if 1+ rpt FOB
if 0+ rpt in 2 years

also at age 55, everyone offered a flexible sigmoidoscopy, 1/3 of those with Ca will be picked up.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

investigations in secondary care for suspected colorectal cancer in order to make the diagnosis?

A

colonoscopy=gold standard
if patients have major comorbidity, can 1st offer flexible sigmoidoscopy then barium enema-apple core stricture
must biopsy any suspicious lesions
consider CT colonography (part. Elderly) as alternative to colonoscopy or flexi sig if local radiology has competence in this technique. This is an effective and safe way of detecting abnormalities using double contrast (gastrograffin), with no need for IV contrast, bowel prep or mobility on the table. However, may get false +ves, and if suspicious lesion should then offer colonoscopy with biospy to confirm diagnosis unless contraindicated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which tumour marker can be monitored in patients with CR Ca to help predict relapse?

A

CEA-elevated pre-treatment levels have -ve prognostic significance
and can be monitored to help predict relapse in patients after surgery suitable for further resection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

use of PET in colorectal Ca?

A

valuable for detection of recurrent colorectal cancer.

17
Q

how is colorectal Ca staged?

A

contrast enhanced staging CT chest/abdo/pelvis.
if rectal Ca, offer MRI as assess risk of local recurrence (determined by anticipated resection margin, and T and N staging), and offer endorectal US if MRI shows disease amenable to local excision or if MRI contraindicated.

18
Q

T stage of bowel Ca that has caused bowel perforation?

A

T4b

19
Q

Dukes staging of colorectal cancer?

A

A-cancer confined to the submucosa (within the bowel wall)
B-through muscularis propria (through bowel wall)
C-regional LN involvement
D-distant metastases

20
Q

purpose of staging in colorectal Ca?

A

assess extent of local and distant disease, to determine operability and treatment choice, and overall prognosis.

21
Q

colorectal Ca grading?

A

1-3
1=well differentiated
2=moderately differentiated
3=poorly differentiated

22
Q

definitive treatment of colorectal Ca?

A

SURGERY
colon cancer: surgery with or without adjuvant chemotherapy
rectal cancer: surgery with or without neoadjuvant radiotherapy or chemoradiotherapy (for those with T3 (into serosa but not through) or T4 disease with or without adjuvant chemotherapy.

23
Q

overall treatment of rectal cancer?

A

surgery=usually definitive treatment of choice
if resectable primary tumour:
consider neoadjuvant radiotherapy if moderate risk rectal cancer
consider neoadjuvant chemoradiotherapy if moderate to high, or high risk rectal cancer
if stage 1 rectal cancer, can be considerd for trial, may give low energy contact X-ray brachytherapy
consider adjuvant chemo in high risk stage II and all stage III rectal Ca to reduce risk of local and systemic recurrence.
if high risk locally advanced offer pre-op chemoradiotherapy with interval before surgery to allow tumour response and shrinkage.

24
Q

recommendations for adjuvant chemo in colon cancer?

A

consider in stage I disease if involved resection margins
consider in high risk stage II
stage III (Duke’s C): capecitabine (prodrug converted to 5-FU) as monotherapy or oxaliplatin in comb with 5-FU and folinic acid.

25
Q

aim of chemotherapy in CR Ca patients with metastatic disease?

A

improve survival and quality of life

26
Q

f/u of patients following treatment of CR Ca?

A

start f/u in those with primary Ca undergoing treatment with curative intent with clinic visit 4-6wks after potentially curative treatment.
regular surveillence: minimun 2 CTs chest/abdo/pelvis in 1st 3 years and CEA at least every 6mnths in 1st 3 years.
surveillence colonoscopy at 1 year, then at 5 years if 1st is normal.

27
Q

palliative surgical options in bowel cancer?

A

stent insertion e.g. when pt presents with acute large bowel obstruction
bypass
defunctioning stoma
palliative resection

28
Q

indications for 2ww referral in CR Ca?

A

40 and over with unexplained weight loss and abdo pain OR
50 and over with unexplained rectal bleeding OR
60 and over with Fe deficiency anaemia OR change in bowel habit OR
tests show occult blood in faeces:
offer to those WITHOUT PR bleeding if:
50 and over with unexplained weight loss or abdo pain OR
under 60 with changes in bowel habit or Fe deficiency anaemia OR
60 and over and have anaemia even in absence of Fe deficiency.

consider 2ww if rectal or abdo mass
consider 2ww in those under 50 with rectal bleeding AND abdo pain OR weight loss OR change in bowel habit OR Fe deficiency anaemia.

29
Q

What proportion of people who do the FOB bowel cancer screening will be found to have Ca?

A

of those that do the FOB, 2% will have an abnormal result

of those that then go on to have a colonoscopy, 10% will have CR Ca

30
Q

where is CR Ca more likely to be located in HNPCC?

A

R side (caecum, descending colon)

31
Q

what criteria can be used to help identify families with HNPCC?

A

Amsterdam criteria:
3 or more relatives with histologically diagnosed CR carcinoma, 1 of whom is a 1st degree relative of the other 2 (FAP should be excluded)
at least 2 successive generations involved
at least 1 relative under 50yrs when diagnosed